Several prescription opioids are significantly stronger than morphine. Fentanyl, the most widely known, is roughly 50 to 100 times more potent. Hydromorphone, oxymorphone, and a handful of ultra-potent compounds used only in specialized settings round out the list, each with a different potency ratio and clinical role.
Potency here means how much of a drug is needed to produce the same level of pain relief as a given dose of morphine. A “stronger” opioid isn’t necessarily better or more effective. It simply means a smaller physical dose achieves the same result. Clinicians use morphine milligram equivalents (MME) as a universal yardstick to compare these drugs.
Fentanyl: 50 to 100 Times Stronger
Fentanyl is the most commonly prescribed opioid that dramatically outpaces morphine in potency. When given intravenously, 1 microgram of fentanyl equals roughly 0.3 milligrams of oral morphine, making it about 100 times more potent by weight in that form. The transdermal patch version (the slow-release skin patch) carries a CDC conversion factor of 2.4, meaning each microgram-per-hour of the patch corresponds to 2.4 milligrams of oral morphine per day.
What makes fentanyl distinct isn’t just its potency but its speed. It reaches peak effect in the brain within about 7 minutes after IV administration, far faster than morphine. That rapid onset is useful during surgery and for managing sudden spikes of severe pain, but it also makes the drug particularly dangerous outside a medical setting. In studies of opioid-naive individuals, a fentanyl blood concentration of just 0.68 nanograms per milliliter was enough to suppress breathing by 50%. Even people with chronic opioid tolerance experienced apnea: 88% stopped breathing temporarily after a cumulative dose of 1.8 milligrams.
Hydromorphone: 5 to 7 Times Stronger
Hydromorphone (brand name Dilaudid) is one of the most frequently used alternatives when morphine isn’t controlling pain well enough or is causing too many side effects. Taken by mouth, 1 milligram of hydromorphone equals about 5 milligrams of oral morphine, making it roughly five times more potent. By IV, the ratio climbs to about 6.7 times stronger: just 0.15 milligrams of IV hydromorphone matches 1 milligram of IV morphine.
Hydromorphone is commonly used in hospitals for acute pain, post-surgical care, and cancer-related pain. Its higher potency per milligram means smaller volumes are needed, which can matter when patients have difficulty swallowing or need concentrated doses through a pump.
Oxymorphone: 3 Times Stronger by Mouth
Oxymorphone is about three times more potent than oral morphine, milligram for milligram. It carries an MME conversion factor of 3.0, so a 10-milligram oxymorphone tablet delivers pain relief equivalent to 30 milligrams of morphine. Given intravenously, the gap widens further: 1 milligram of IV oxymorphone equals roughly 30 milligrams of oral morphine.
Oxymorphone fills a middle ground between morphine and the much stronger fentanyl. It’s prescribed for severe pain that requires around-the-clock management, typically in patients who’ve already been on other opioids and need something more potent.
Methadone: Potency That Increases With Dose
Methadone is unusual because its relative strength compared to morphine isn’t fixed. At lower doses, the CDC assigns it a conversion factor of 4.7, making it nearly five times stronger than morphine. But at higher doses, methadone’s potency climbs disproportionately, sometimes reaching 10 to 12 times the strength of an equivalent morphine dose. This nonlinear relationship makes methadone one of the trickiest opioids to dose safely and is a major reason why switching to or from methadone requires careful medical supervision.
Sufentanil and Carfentanil: The Extremes
At the far end of the potency spectrum sit compounds that are rarely, if ever, encountered in routine medical care. Sufentanil is roughly 5 to 10 times more potent than fentanyl (500 to 1,000 times stronger than morphine) and is used almost exclusively during cardiac surgery and in specialized pain management devices.
Carfentanil is 10,000 times more potent than morphine and 100 times more potent than fentanyl, according to the U.S. Department of Veterans Affairs. It has no approved use in humans. It was developed as a tranquilizer for very large animals like elephants. Even a few micrograms can be lethal to a person, and its appearance in the illicit drug supply has been linked to mass overdose events.
Weaker Opioids for Context
Not every opioid sits above morphine on the potency scale, and understanding the full range helps put the stronger drugs in perspective. Oxycodone is 1.5 times stronger than morphine. Hydrocodone is roughly equal to morphine (conversion factor of 1.0). Codeine is far weaker, at just 0.15 times morphine’s strength, meaning you’d need about 200 milligrams of codeine to match 30 milligrams of morphine. Tramadol is weaker still, with a factor of 0.2.
Why “Stronger” Doesn’t Mean “Better”
A more potent opioid doesn’t automatically provide superior pain relief. All full opioid agonists can theoretically achieve the same ceiling of pain control if dosed high enough. The practical reasons for choosing a stronger drug include needing smaller volumes for injection, faster onset during emergencies, or switching when a patient’s body has stopped responding well to one particular opioid.
That switch itself carries risk. When moving from one opioid to another, clinicians typically reduce the calculated equivalent dose by 25% to 50%. This accounts for a phenomenon called incomplete cross-tolerance: your body’s tolerance to one opioid doesn’t fully transfer to a different one, even at the “same” potency on paper. Skipping that dose reduction is a common cause of accidental overdose during opioid rotation.
Respiratory Depression: The Core Danger
Every opioid stronger than morphine shares the same life-threatening risk, just compressed into a smaller dose. Respiratory depression, where breathing slows or stops entirely, is the primary cause of opioid overdose death. The more potent the drug, the smaller the margin between a therapeutic dose and a dangerous one.
Fentanyl illustrates this vividly. In controlled research settings, 16% of participants experienced apnea (complete cessation of breathing) after a 0.5-milligram dose, and 59% experienced it at 2 milligrams. People who had never taken opioids before were 3.3 times more sensitive to fentanyl’s breathing suppression than those with chronic opioid exposure. This narrow safety window is why high-potency opioids are reserved for situations where close monitoring is possible or where tolerance has already been established with weaker drugs.